Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Ricardo AC, Anderson CA, Yang W, Zhang X, Fischer MJ, Dember LM, Fink JC, Frydrych A, Jensvold NG, Lustigova E, Nessel LC, Porter AC, Rahman M, Wright Nunes JA, Daviglus ML, Lash JP; CRIC Study Investigators.

Am J Kidney Dis. 2015 Mar;65(3):412-24. doi: 10.1053/j.ajkd.2014.09.016. Epub 2014 Nov 20.

2.

APOL1 risk variants, race, and progression of chronic kidney disease.

Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators.

N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.

3.

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, Ojo A, Teal VL, Jensvold NG, Robinson NL, Dries DL, Bazzano L, Mohler ER, Wright JT, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group.

Am Heart J. 2010 Jun;159(6):1102-7. doi: 10.1016/j.ahj.2010.03.027. Erratum in: Am Heart J. 2010 Dec;160(6):1190. Am Heart J. 2011 Oct;162(4):794.

4.

Death and disability from warfarin-associated intracranial and extracranial hemorrhages.

Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, Singer DE.

Am J Med. 2007 Aug;120(8):700-5. Epub 2007 May 24.

5.

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.

Fang MC, Go AS, Hylek EM, Chang Y, Henault LE, Jensvold NG, Singer DE.

J Am Geriatr Soc. 2006 Aug;54(8):1231-6.

6.

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS.

Circulation. 2005 Sep 20;112(12):1687-91. Epub 2005 Sep 12.

7.

Gender and risk of adverse outcomes in heart failure.

Lee WY, Capra AM, Jensvold NG, Gurwitz JH, Go AS; Epidemiology, Practice, Outcomes, and Cost of Heart Failure (EPOCH) Study.

Am J Cardiol. 2004 Nov 1;94(9):1147-52.

PMID:
15518609
8.

Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs.

Farber HJ, Chi FW, Capra A, Jensvold NG, Finkelstein JA, Lozano P, Quesenberry CP Jr, Lieu TA.

Ann Allergy Asthma Immunol. 2004 Mar;92(3):319-28.

PMID:
15049395
10.

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.

JAMA. 2003 Nov 26;290(20):2685-92.

PMID:
14645310
11.

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.

N Engl J Med. 2003 Sep 11;349(11):1019-26.

12.

Clinician support and psychosocial risk factors associated with breastfeeding discontinuation.

Taveras EM, Capra AM, Braveman PA, Jensvold NG, Escobar GJ, Lieu TA.

Pediatrics. 2003 Jul;112(1 Pt 1):108-15.

PMID:
12837875
13.

Misunderstanding of asthma controller medications: association with nonadherence.

Farber HJ, Capra AM, Finkelstein JA, Lozano P, Quesenberry CP, Jensvold NG, Chi FW, Lieu TA.

J Asthma. 2003 Feb;40(1):17-25.

PMID:
12699208
14.

Strategies for surveying families of Medicaid-insured children by telephone.

Jensvold NG, Lieu TA, Chi FW, Capra AM, Sisk CA.

J Health Care Poor Underserved. 2003 Feb;14(1):17-22. No abstract available.

PMID:
12613065
15.

Racial/ethnic variation in asthma status and management practices among children in managed medicaid.

Lieu TA, Lozano P, Finkelstein JA, Chi FW, Jensvold NG, Capra AM, Quesenberry CP, Selby JV, Farber HJ.

Pediatrics. 2002 May;109(5):857-65.

PMID:
11986447
16.

A randomized comparison of home and clinic follow-up visits after early postpartum hospital discharge.

Lieu TA, Braveman PA, Escobar GJ, Fischer AF, Jensvold NG, Capra AM.

Pediatrics. 2000 May;105(5):1058-65.

PMID:
10790463
17.

Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983-1987.

Shaw GM, Jensvold NG, Wasserman CR, Lammer EJ.

Teratology. 1994 Feb;49(2):143-9.

PMID:
8016745
18.

Birth defects monitoring in California: a resource for epidemiological research.

Croen LA, Shaw GM, Jensvold NG, Harris JA.

Paediatr Perinat Epidemiol. 1991 Oct;5(4):423-7.

PMID:
1754501

Supplemental Content

Loading ...
Support Center